A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade

Jerby-Arnon, Livnat, Shah, Parin, Cuoco, Michael S., Rodman, Christopher, Su, Mei-Ju, Melms, Johannes C., Leeson, Rachel, Kanodia, Abhay +44 more·2018·Cell

DOI 10.1016/j.cell.2018.09.006

Cited by (999)

Items 701–800 of 999

Buffy Coat Immunotranscriptomics for Diagnosis of Malignant Pleural Mesothelioma
Gerardo Velez, Harvey Ira Pass, Michele Carbone, Haining Yang, Chandra M. V. Goparaju · 2021 · Cancer Research Journal
Pan-cancer single cell RNA-seq uncovers recurring programs of cellular heterogeneity
Gabriela Sarti Kinker, Alissa Greenwald, Rotem Tal, Zhanna Orlova, Michael S. Cuoco, James M. McFarland, Allison C. Warren, Christopher Rodman, Jennifer A. Roth, Samantha A. Bender et al. · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
Integrated cancer cell-specific single-cell RNA-seq datasets of immune checkpoint blockade-treated patients
M. Gondal, M. Cieslik, A. Chinnaiyan · 2025 · Scientific Data
Multiregional single-cell transcriptomics reveals an association between partial EMT and immunosuppressive states in oral squamous cell carcinoma
Seunghoon Kim, Hyun Jung Kee, Dahee Kim, Jinho Jang, Hyoung‐oh Jeong, Nam Suk Sim, Mischa Selig, Jana Ihlow, Livius Penter, Taejoo Hwang et al. · 2025 · iScience
CDK12/13 inactivation triggers STING-mediated antitumor immunity in preclinical models
Yi Bao, Yu Chang, J. Tien, Gabriel Cruz, Fan Yang, R. Mannan, Somnath Mahapatra, Radha Paturu, Xu-Hong Cao, Feng-Yun Su et al. · 2025 · Journal of Clinical Investigation
Harnessing multi-omics and machine learning for predicting immune checkpoint blockade responses: Advances, challenges, and future directions
Shiwei Cao, Junwei Liu, Y Li · 2025 · Fundamental Research
Immune cell senescence drives responsiveness to immunotherapy in melanoma
Pavlos Pantelis, Dimitrios Christos Tremoulis, Konstantinos Evangelou, Panagiotis Bakouros, Sophia Magkouta, Orestis A. Ntintas, Dimitris Veroutis, Giorgos Theocharous, Ioannis V. Kostopoulos, Dimitris-Foivos Thanos et al. · 2025 · Molecular Cancer
Single‐Cell and Spatial Omics: Methods and Applications
Xiaoping Cen, Xiaolan Huang, Erle Deng, Xue Gong, Na Tan, J. T. Ye, Yin Wang, Roland Eils, Qun Luo, Yixue Li et al. · 2026 · MedComm
Mapping intratumor heterogeneity across layers for advancing immunotherapy
Jean‐Christophe Marine, Osnat Bartok, Shira Sagie, Pietro Paolo Vitiello, Alberto Bardelli, Chen Weller, Tiangen Chang, Claudia Tonelli, Stefani Spranger, Eytan Ruppin et al. · 2026 · Cell
Clinical and Molecular Correlates of NLRC5 Expression in Patients With Melanoma
Lei Lv, Qinqin Wei, Zhiwen Wang, Yujia Zhao, Ni Chen, Qiyi Yi · 2021 · Frontiers in Bioengineering and Biotechnology
Identification of Transcriptional Heterogeneity and Construction of a Prognostic Model for Melanoma Based on Single-Cell and Bulk Transcriptome Analysis
Zijian Kang, Jing Wang, Wending Huang, Jianmin Liu, Wangjun Yan · 2022 · Frontiers in Cell and Developmental Biology
Specificity and function of T cell subset identities using single‐cell sequencing
Xuanqi Liu, Zhenhua Zhu, Xiangdong Wang · 2023 · Clinical and Translational Discovery
Comparative Analysis of Cell Mixtures Deconvolution and Gene Signatures Generated for Blood, Immune and Cancer Cells
Natalia Alonso-Moreda, Alberto Berral-González, Enrique De La Rosa, Óscar González-Velasco, José Manuel Sánchez-Santos, Javier De Las Rivas · 2023 · International Journal of Molecular Sciences
DUX4 is a common driver of immune evasion and immunotherapy failure in metastatic cancers
Jose Mario Bello Pineda, Robert K. Bradley · 2023 · eLife
Melanoma Clonal Heterogeneity Leads to Secondary Resistance after Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes
David König, Michael T. Sandholzer, Sarp Uzun, Andreas Zingg, Reto Ritschard, Helen Thut, Katharina Glatz, Elisabeth A. Kappos, Dirk J. Schaefer, Christoph Kettelhack et al. · 2024 · Cancer Immunology Research
Spatial transcriptomics reveals influence of microenvironment on intrinsic fates in melanoma therapy resistance
Ryan H. Boe, Catherine G. Triandafillou, Rossana Lazcano, Jennifer Ann Wargo, Arjun Raj · 2026 · Genome biology
The classification of melanocytic gene signatures
Min Hu, Samuel S. Coleman, Robert L. Judson‐Torres, Aik Choon Tan · 2024 · Pigment Cell & Melanoma Research
A machine learning model reveals expansive downregulation of ligand-receptor interactions that enhance lymphocyte infiltration in melanoma with developed resistance to immune checkpoint blockade
Sahil Sahni, Binbin Wang, Di Wu, Saugato Rahman Dhruba, Matthew R. Nagy, Sushant Patkar, Ingrid Ferreira, Chi‐Ping Day, Kun Wang, Eytan Ruppin · 2024 · Nature Communications
Immune senescence: A key player in cancer biology
Yanru Yang, Linni Fan, Mingyang Li, Zhe Wang · 2024 · Seminars in Cancer Biology
Overcoming resistance to immunotherapy by targeting CD38 in human tumor explants
Or‐Yam Revach, Angelina M. Cicerchia, Ofir Shorer, Claire A. Palin, Boryana Petrova, Seth Anderson, Baolin Liu, Joshua C. Park, Lee Chen, Arnav Mehta et al. · 2025 · Cell Reports Medicine
Cell Cycle Dysregulation in Mantle Cell Lymphoma
Kevin Wang, Xiangao Huang, Maurizio Di Liberto, Selina Chen‐Kiang · 2020 · Hematology/Oncology Clinics of North America
A Novel Prognostic Signature Revealed the Interaction of Immune Cells in Tumor Microenvironment Based on Single-Cell RNA Sequencing for Lung Adenocarcinoma
Xing Jin, Zhengyang Hu, Qihai Sui, Mengnan Zhao, Jiaqi Liang, Zhenyu Liao, Yuansheng Zheng, Hao Wang, Yu Shi · 2022 · Journal of Immunology Research
SRC-RAC1 signaling drives drug resistance to BRAF inhibition in de-differentiated cutaneous melanomas
Eliot Y. Zhu, Jesse D. Riordan, Marion Vanneste, Michael D. Henry, Christopher S. Stipp, Adam J. Dupuy · 2022 · npj Precision Oncology
Effect of stress-induced polyploidy on melanoma reprogramming and therapy resistance
Svenja Meierjohann · 2021 · Seminars in Cancer Biology
Risk Models for Advanced Melanoma Patients Under Anti-PD-1 Monotherapy—Ad hoc Analyses of Pooled Data From Two Clinical Trials
Xue Li Bai, Jie Dai, Caili Li, Chuanliang Cui, Lili Mao, Xiaoting Wei, Xinan Sheng, Zhihong Chi, Xieqiao Yan, Bixia Tang et al. · 2021 · Frontiers in Oncology
CD4 + follicular helper-like T cells are key players in anti-tumor immunity
Divya Kumari Singh, AP Ganesan, Bharat Panwar, Simon Eschweiler, Christopher Jon Hanley, Ariel Madrigal, Ciro Ramírez-Suástegui, A Wang, James D. Clarke, Oliver Wood et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
An integrative analysis of the single-cell transcriptome identifies DUSP4 as an exhaustion-associated gene in tumor-infiltrating CD8+ T cells
Yu Chen Zhao, Huihui Cai, Xiaoling Ding, Xiaorong Zhou · 2023 · Functional & Integrative Genomics
Mechanisms and clinical implications in renal carcinoma resistance: narrative review of immune checkpoint inhibitors
Samnani, Sunil, Sachedina, Faraz, Gupta, Mehul, Guo, Edward, Navani, Vishal · 2023 · Cancer Drug Resistance
Identification of cell subpopulations associated with disease phenotypes from scRNA-seq data using PACSI
Chonghui Liu, Yan Zhang, Xin Gao, Guohua Wang · 2023 · BMC Biology
ERK hyperactivation serves as a unified mechanism of escape in intrinsic and acquired CDK4/6 inhibitor resistance in acral lentiginous melanoma
Kasturee Jagirdar, Marie Elena Portuallo, Meihan Wei, Matthew Wilhide, Jeremy Bravo, Bailey M. Robertson, Gretchen Marie Alicea, Crystal Aguh, Min Xiao, Tetiana Godok et al. · 2023 · Oncogene
Highlighting roles of autophagy in human diseases: a perspective from single-cell RNA sequencing analyses
Anis Khalafiyan, Mahmood Fadaie, Fatemeh Khara, Ali Zarrabi, Fariborz Moghadam, Hossein Khanahmad, Marco Cordani, Maryam Boshtam · 2024 · Drug Discovery Today
Pan-inhibition of super-enhancer-driven oncogenic transcription by next-generation synthetic ecteinascidins yields potent anti-cancer activity
Max Cigrang, Julian Obid, Maguelone Nogaret, Léane Seno, Tao Ye, Guillaume Davidson, Philippe Catez, Pietro Berico, Clara Capelli, Clara Marechal et al. · 2025 · Nature Communications
Carboxylesterase 1-mediated endocannabinoid metabolism in skin: role in melanoma progression in BRafV600E/Pten−/− mice
Veronika Morozova, Daniele Pellegata, Roch‐Philippe Charles, Jürg Gertsch · 2025 · Cancer & Metabolism
Single-cell RNA sequencing reveals the existence of pro-metastatic subpopulation within a parental B16 murine melanoma cell line
Yoon‐Seob Kim, Sun Young Shin, Jing Hu Yin, Junseong Park, Seung‐Hyun Jung, Yeun‐Jun Chung · 2022 · Biochemical and Biophysical Research Communications
An In Vivo Model of Human Macrophages in Metastatic Melanoma
Valentin Voillet, Trisha R. Berger, Kelly Marie McKenna, Kelly Garneski Paulson, Wei Hong Tan, Kimberly S. Smythe, Daniel S. Hunter, William J. Valente, Stephanie Weaver, Jean S. Campbell et al. · 2022 · The Journal of Immunology
MYC Induces Immunotherapy and IFNγ Resistance Through Downregulation of JAK2
Ettai Markovits, Ortal Harush, Erez N. Baruch, Eldad David Shulman, Assaf Debby, Orit Itzhaki, Liat Anafi, Artem Danilevsky, Noam Shomron, Guy Ben‐Betzalel et al. · 2023 · Cancer Immunology Research
Bulk and single-cell RNA-sequencing analyses along with abundant machine learning methods identify a novel monocyte signature in SKCM
Yuyao Liu, Haoxue Zhang, Yan Mao, Yangyang Shi, Xu Wang, Shaomin Shi, Delin Hu, Shengxiu Liu · 2023 · Frontiers in Immunology
Correlation of the tumor escape phenotype with loss of PRELP expression in melanoma
Helene Schäfer, Karthikeyan Subbarayan, Chiara Massa, Christoforos Vaxevanis, Anja Mueller, Barbara Seliger · 2023 · Journal of Translational Medicine
Treatment with the PPARα agonist fenofibrate improves the efficacy of CD8+ T cell therapy for melanoma
Mohadeseh Hasanpourghadi, Arezki Chekaoui, Sophia Kurian, Raj K. Kurupati, Robert Ambrose, Wynetta Giles‐Davis, Amara Saha, Xiaowei Xu, Hildegund C.J. Ertl · 2023 · Molecular Therapy — Oncolytics
Advances in the Characterization of Circulating Tumor Cells in Metastatic Breast Cancer: Single Cell Analyses and Interactions, and Patient-Derived Models for Drug Testing
Praveen Kumar Kujur, Bianca C. T. Flores, Naveen Ramalingam, Ludmilla Thomé Domingos Chinen, Stefanie S. Jeffrey · 2020 · Advances in experimental medicine and biology
TMExplorer: A tumour microenvironment single-cell RNAseq database and search tool
Erik Christensen, Alaine Naidas, David J. Chen, Mia Husić, Parisa Shooshtari · 2022 · PLoS ONE
Single-cell gene regulatory network analysis reveals new melanoma cell states and transition trajectories during phenotype switching
Jasper Wouters, Zeynep Kalender Atak, Liesbeth Minnoye, Katina I. Spanier, Maxime De Waegeneer, Carmen Bravo González‐Blas, David Mauduit, Kristofer Davie, Gert J. Hulselmans, Ahmad Najem et al. · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
Building a unified model for drug synergy analysis powered by large language models
Tianyu Liu, Tinyi Chu, Xiao Luo, Hongyu Zhao · 2025 · Nature Communications
Neuro–immune–tumor axis in gliomas: a review of mechanisms, models, and translational opportunities
Xu Lu, Shuangyu Chen, Yixin Fu, Tingting Zhou, Jianghao Yu, Jiayang Li, Wei Chen · 2025 · Frontiers in Immunology
IFNγ-dependent metabolic reprogramming restrains an immature, pro-metastatic lymphatic state in melanoma
Triantafyllia R. Karakousi, Vanessa Cristaldi, Maria Luiza Lopes de Oliveira, Ines Delclaux, Naomi R. Besson, Luiz Henrique Geraldo, Tania J González-Robles, Devyon R. McDonnough, Daniel Martinez-Krams, Gabrielle Silva et al. · 2026 · Cancer Cell
Engineering NK and T cells with metabolite-sensing receptors to target solid tumors
Young‐Min Kim, Min K. Tsai, Chang Sun, Olivia Laveroni, Reece Villarin Akana, Kristen R. Frombach, Livnat Jerby‐Arnon · 2026 · Nature Immunology
A novel gene signature unveils three distinct immune-metabolic rewiring patterns conserved across diverse tumor types and associated with outcomes
Leire Pedrosa, Carles Foguet, Helena Oliveres, Iván Archilla, Marta García de Herreros, A. Rodríguez, Antonio A. Postigo, Daniel Benítez‐Ribas, Jordi Camps, Míriam Cuatrecasas et al. · 2022 · Frontiers in Immunology
An advanced comprehensive muti-cell-type-specific model for predicting anti-PD-1 therapeutic effect in melanoma
Wei Sun, Yu Zhu, Zijian Zou, Lu Wang, Jingqin Zhong, Kangjie Shen, Xinyi Lin, Zixu Gao, Wanlin Liu, Yinlam Li et al. · 2024 · Theranostics
Unravelling the metabolic landscape of cutaneous melanoma: Insights from single‐cell sequencing analysis and machine learning for prognostic assessment of lactate metabolism
Jiaheng Xie, Pengpeng Zhang, Chenfeng Ma, Qikai Tang, Xinxin Zhou, Xiaolong Xu, Min Zhang, Songyun Zhao, Liping Zhou, Min Qi · 2024 · Experimental Dermatology
Where Are We Now with Oncolytic Viruses in Melanoma and Nonmelanoma Skin Malignancies?
George Nassief, Angela Anaeme, Karen Moussa, David Y. Chen, George Ansstas · 2024 · Pharmaceuticals
Double-Faced Immunological Effects of CDK4/6 Inhibitors on Cancer Treatment: Challenges and Perspectives
Yongqin Liu, Yiying Deng, Chang Yang, Hua Naranmandura · 2024 · Bioengineering
Multi-omics analysis and experiments uncover the function of cancer stemness in ovarian cancer and establish a machine learning-based model for predicting immunotherapy responses
Zhibing Liu, Lei Han, Xiaoyu Ji, Xiaole Wang, Jinbo Jian, Yujie Zhai, Yingjiang Xu, Feng Wang, Xiuwen Wang, Fangling Ning · 2024 · Frontiers in Immunology
Reciprocal Modulation of Tumour and Immune Cell Motility: Uncovering Dynamic Interplays and Therapeutic Approaches
Angelo Aquino, Ornella Franzese · 2025 · Cancers
Deciphering the Immunomodulatory Function of GSN + Inflammatory Cancer‐Associated Fibroblasts in Renal Cell Carcinoma Immunotherapy: Insights From Pan‐Cancer Single‐Cell Landscape and Spatial Transcriptomics Analysis
Shan Li, Xinwei Zhou, Haoqian Feng, Kangbo Huang, Minyu Chen, Mingjie Lin, Hansen Lin, Zebing Deng, Yuhang Chen, Wuyuan Liao et al. · 2025 · Cell Proliferation
Claudin-Low Breast Cancer Inflammatory Signatures Support Polarization of M1-Like Macrophages with Protumoral Activity
Mayra Cecilia Suárez-Arriaga, Alfonso Méndez-Tenorio, Vadim Pérez‐Koldenkova, Ezequiel M. Fuentes‐Pananá · 2021 · Cancers
Melanoma Immunotherapy and Precision Medicine in the Era of Tumor Micro-Tissue Engineering: Where Are We Now and Where Are We Going?
Francesca Varrone, Luigi Mandrich, Emilia Caputo · 2021 · Cancers
Tyrosine-Dependent Phenotype Switching Occurs Early in Many Primary Melanoma Cultures Limiting Their Translational Value
Ahmad Najem, Jasper Wouters, Mohammad Krayem, Florian Rambow, Malak Sabbah, François Salès, Ahmad Hussein Awada, Stein Aerts, Fabrice Journé, Jean‐Christophe Marine et al. · 2021 · Frontiers in Oncology
A Commotion in the Skin: Developing Melanoma Immunotherapies
Ellen Brenner, Martin Röcken · 2022 · Journal of Investigative Dermatology
Melanoma 2.0. Skin cancer as a paradigm for emerging diagnostic technologies, computational modelling and artificial intelligence
Julio Vera, Xin Lai, Andreas S. Baur, Michael Erdmann, Shailendra K. Gupta, Cristiano Guttà, Lucie Heinzerling, Markus Vincent Heppt, Philipp Maximilian Kazmierczak, Manfred Kunz et al. · 2022 · Briefings in Bioinformatics
Radiomics-guided checkpoint inhibitor immunotherapy for precision medicine in cancer: A review for clinicians
Huijie Zhou, Qian Luo, Wanchun Wu, Na Li, Yang Chunli, Liqun Zou · 2023 · Frontiers in Immunology
Melanoma Single-Cell Biology in Experimental and Clinical Settings
Hans Binder, Maria Schmidt, Henry Loeffler‐Wirth, Lena Sünke Mortensen, Manfred Kunz · 2021 · Journal of Clinical Medicine
A tumor mutational burden-derived immune computational framework selects sensitive immunotherapy/chemotherapy for lung adenocarcinoma populations with different prognoses
Wenlong Zhang, Chuzhong Wei, Fengyu Huang, Wen‐Cheng Huang, Xiaoxin Xu, Xiao Ming Zhu · 2023 · Frontiers in Oncology
The Unmet Needs of the Diagnosis, Staging, and Treatment of Gastrointestinal Tumors
Niels Halama, Uwe Haberkorn · 2020 · Seminars in Nuclear Medicine
Bayesian cell-type deconvolution and gene expression inference reveals tumor-microenvironment interactions
Tinyi Chu, Zhong Wang, Dana Pe’er, Charles G. Danko · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
Pan-cancer landscape of AID-related mutations, composite mutations, and their potential role in the ICI response
Isaias Hernández-Verdín, Kadir Caner Akdemir, Daniele Ramazzotti, Giulio Caravagna, Karim Labrèche, Karima Mokhtari, Khê Hoang‐Xuan, Matthieu Peyre, Franck Bielle, Mehdi Touat et al. · 2022 · npj Precision Oncology
Single-cell Technologies Provide Novel Insights into Liver Physiology and Pathology
Guanzi Chen, Wenli Xu, Zhicong Long, Yutian Chong, Bingliang Lin, Yusheng Jie · 2023 · Journal of Clinical and Translational Hepatology
MHC class Ib–restricted CD8 + T cells possess strong tumoricidal activities
Qing Li, Liangyu Lin, Peishun Shou, Keli Liu, Yueqing Xue, Mingyuan Hu, Weifang Ling, Yin Huang, Liming Du, Chunxing Zheng et al. · 2023 · Proceedings of the National Academy of Sciences
FGL1 in plasma extracellular vesicles is correlated with clinical stage of lung adenocarcinoma and anti-PD-L1 response
Yuchen Zhang, Kunpeng Zhang, Haoyu Wen, Di Ge, Jie Gu, C. Zhang · 2023 · Clinical & Experimental Immunology
The molecular map of CLL and Richter's syndrome
Amit Sud, Erin Michelle Parry, Catherine J. Wu · 2024 · Seminars in Hematology
ADGRE5-centered Tsurv model in T cells recognizes responders to neoadjuvant cancer immunotherapy
Jian Li, Zhouwenli Meng, Zhengqi Cao, Wenqing Lü, Yi Yang, Ziming Li, Shun Lü · 2024 · Frontiers in Immunology
Single-cell RNA sequencing reveals melanoma cell state-dependent heterogeneity of response to MAPK inhibitors
Su Yin Lim, Yingxin Lin, Jenny Lee, Bernadette Pedersen, Ashleigh Stewart, Richard A. Scolyer, Georgina Venetia Long, Jean Yee Hwa Yang, Helen Rizos · 2024 · EBioMedicine
Recent Advancements in Cell-Based Therapies in Melanoma
George Nassief, Angela Anaeme, Karen Moussa, Abdallah Mansour, George Ansstas · 2024 · International Journal of Molecular Sciences
MYO1F regulates T-cell activation and glycolytic metabolism by promoting the acetylation of GAPDH
Zhihui Cui, Heping Wang, Xiong Feng, Chuyu Wu, Ming Yi, Ruirui He, Ting Pan, Ru Gao, Lingyun Feng, Bo Zeng et al. · 2024 · Cellular and Molecular Immunology
Metabolic Inhibition Induces Pyroptosis in Uveal Melanoma
Scott D. Varney, Dan A. Erkes, Glenn L. Mersky, Manal U. Mustafa, Vivian Y.L. Chua, Inna Chervoneva, Timothy J. Purwin, Emad S. Alnemri, Andrew E. Aplin · 2024 · Molecular Cancer Research
Single-cell RNA sequencing: enhancing the predictive accuracy of tumor immunotherapy efficacy
Wei Zhou, Ziwei Huang, Zhiyun Wu, Mengyuan Tang, Linqi Zhu, Weifeng Shi, Qi Wang, Liangzhu Feng · 2025 · Essays in Biochemistry
Low expression of endoplasmic reticulum stress-related gene SERP1 is associated with poor prognosis and immune infiltration in skin cutaneous melanoma
Yuchao Fan, Liang Xiao, Deshui Yu · 2021 · Aging
Miscell: An efficient self-supervised learning approach for dissecting single-cell transcriptome
Hongru Shen, Yang Li, Mengyao Feng, Xilin Shen, Dan Wu, Chao Zhang, Yichen Yang, Meng Yang, Jiani Hu, Jilei Liu et al. · 2021 · iScience
GDPLichi: a DNA Damage Repair-Related Gene Classifier for Predicting Lung Adenocarcinoma Immune Checkpoint Inhibitors Response
Yang Leng, Shiying Dang, Fei Yin, Tianshun Gao, Xing Xiao, Yi Zhang, Lin Chen, Changfei Qin, Nannan Lai, Xiao-Yong Zhan et al. · 2021 · Frontiers in Oncology
Unravelling Tumour Microenvironment in Melanoma at Single-Cell Level and Challenges to Checkpoint Immunotherapy
Xinyu Bai, Camelia Y. J. Quek · 2022 · Genes
Fibrinogen like protein-1 knockdown suppresses the proliferation and metastasis of TU-686 cells and sensitizes laryngeal cancer to LAG-3 blockade
Jiameng Huang, Qiang Huang, Jiyao Xue, Huiqin Liu, Yang Guo, Hui Chen, Liang Fu Zhou · 2022 · Journal of International Medical Research
IRF1 expression might be a biomarker of CD8+ T cell infiltration in cutaneous melanoma
Shijie Zhou, Chunli Lu, Gan Liu, Qinsheng Hu, Jinliang Yang · 2022 · Expert Review of Clinical Immunology
Preclinical evaluation of CDK4 phosphorylation predicts high sensitivity of pleural mesotheliomas to CDK4 /6 inhibition
Sabine Paternot, Eric Raspé, Clément Meiller, Maxime Tarabichi, Jean‐Baptiste Assié, Frédérick Libert, Myriam Remmelink, Xavier Bisteau, Patrick Pauwels, Yuna Blum et al. · 2022 · Molecular Oncology
Pan-cancer investigation of C-to-U editing reveals its important role in cancer development and new targets for cancer treatment
Mengbiao Guo, Feng Li, Linghao Zhao, Zhengwen Fang, Huichuan Yu, Zhou Songyang, Yuanyan Xiong · 2023 · Frontiers in Oncology
Expression of lymphoid structure-associated cytokine/chemokine gene transcripts in tumor and protein in serum are prognostic of melanoma patient outcomes
Lilit Karapetyan, Hassan Mohammed Abushukair, Aofei Li, Andrew Knight, Ayah Nedal Al-Bzour, Ian MacFawn, Zachary Thompson, Ann Chen, Xi Yang, Rebekah Dadey et al. · 2023 · Frontiers in Immunology
Gene signature reveals decreased SOX10-dependent transcripts in malignant cells from immune checkpoint inhibitor-resistant cutaneous melanomas
Timothy J. Purwin, Signe Caksa, Ahmet Saçan, Claudia Capparelli, Andrew E. Aplin · 2023 · iScience
Recent Advances in Single-Cell RNA-Sequencing of Primary and Metastatic Clear Cell Renal Cell Carcinoma
Adele M. Alchahin, Ιωάννα Τσέα, Ninib Baryawno · 2023 · Cancers
T proliferating cells derived autophagy signature associated with prognosis and immunotherapy resistance in a pan-cancer analysis
Zhongqi Fan, Yutao Liu, Chengcheng Li, Yanfang Jiang, Nanya Wang, Ming-Da Wang, Chao Li, Yong‐Kang Diao, Wei Qiu, Zhu Xin et al. · 2023 · iScience
MET receptor serves as a promising target in melanoma brain metastases
Torben Redmer, Elisa Schumann, Kristin Peters, Martin E. Weidemeier, Stephan Nowak, Henry W. S. Schroeder, Anna Vidal, Helena Radbruch, Annika Lehmann, Susanne Kreuzer-Redmer et al. · 2024 · Acta Neuropathologica
Interleukin-12 elicits a non-canonical response in B16 melanoma cells to enhance survival
Christina Nicole Nikki Byrne-Hoffman, Wentao Deng, Owen McGrath, Peng Wang, Yon Rojanasakul, David J. Klinke · 2020 · Cell Communication and Signaling
Examining heterogeneity of stromal cells in tumor microenvironment based on pan-cancer single-cell RNA sequencing data
Wenhui Wang, Li Wang, Junjun She, Jun Zhu · 2021 · Cancer Biology and Medicine
Personalized Immuno-Oncology
Kewal K. Jain · 2020 · Springer eBooks
Breaking the Immune Complexity of the Tumor Microenvironment Using Single-Cell Technologies
Simone Caligola, Francesco De Sanctis, Stefania Canè, Stefano Ugel · 2022 · Frontiers in Genetics
Associating Immunotherapy and Targeted Therapies: Facts and Hopes
Sylvain Ladoire, Cédric Rébé, François Ghiringhelli · 2022 · Clinical Cancer Research
Whole-genome mapping of small-molecule targets for cancer medicine
Stéphanie Solier, Sebastian Müller, Raphaël Rodriguez · 2020 · Current Opinion in Chemical Biology
Divergent Resistance Mechanisms to Immunotherapy Explain Responses in Different Skin Cancers
Emmanuel Dollinger, Daniel R. Bergman, Peijie Zhou, Scott X. Atwood, Qing Hua Nie · 2020 · Cancers
Severely ill COVID-19 patients display augmented functional properties in SARS-CoV-2-reactive CD8 + T cells
Anthony Kusnadi, Ciro Ramírez-Suástegui, Vicente Fajardo, Serena Chee, Benjamin J. Meckiff, Hayley A. Simon, Emanuela Pelosi, Grégory Seumois, Ferhat Ay, Pandurangan Vijayanand et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
The CD58:CD2 axis is co-regulated with PD-L1 via CMTM6 and governs anti-tumor immunity
Patricia Ho, Johannes C. Melms, Meri Rogava, Chris J. Frangieh, Shivem B. Shah, Zachary H. Walsh, Oleksandr Kyrysyuk, Amit Dipak Amin, Lindsay Caprio, Benjamin T. Fullerton et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
Transitory Schwann Cell Precursor and hybrid states underpin melanoma therapy resistance and metastasis
Vishaka Gopalan, Chun Wai Wong, Rotem Leshem, Luke Owen, Tuulia Vallius, Yingxiao Shi, Yuhong Jiang, Eva Pérez‐Guijarro, Emily Wu, Sung Chin et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
Tumor-reactive clonotype dynamics underlying clinical response to TIL therapy in melanoma
Johanna Chiffelle, David Barras, Rémy Pétremand, Angela Orcurto, Sara Bobisse, Marion Arnaud, Aymeric Auger, Blanca Navarro Rodrigo, Eleonora Ghisoni, Christophe Sauvage et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
Mechanism of resistance to immune checkpoint inhibitors
Manu Raj Pandey, Marc S. Ernstoff · 2019 · Cancer Drug Resistance